BRPI0511372B1 - Produto para inibição do crescimento de bactérias de cárie dentária, e, método para fabricar um produto - Google Patents
Produto para inibição do crescimento de bactérias de cárie dentária, e, método para fabricar um produto Download PDFInfo
- Publication number
- BRPI0511372B1 BRPI0511372B1 BRPI0511372-5A BRPI0511372A BRPI0511372B1 BR PI0511372 B1 BRPI0511372 B1 BR PI0511372B1 BR PI0511372 A BRPI0511372 A BR PI0511372A BR PI0511372 B1 BRPI0511372 B1 BR PI0511372B1
- Authority
- BR
- Brazil
- Prior art keywords
- product
- lactobacillus
- fact
- strain
- mutans
- Prior art date
Links
- 208000002925 dental caries Diseases 0.000 title claims abstract description 31
- 241000894006 Bacteria Species 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims description 14
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 230000017066 negative regulation of growth Effects 0.000 title 1
- 102000015728 Mucins Human genes 0.000 claims abstract description 20
- 108010063954 Mucins Proteins 0.000 claims abstract description 20
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 16
- 238000011282 treatment Methods 0.000 claims abstract description 12
- 229940051875 mucins Drugs 0.000 claims abstract 2
- 241000186660 Lactobacillus Species 0.000 claims description 41
- 229940039696 lactobacillus Drugs 0.000 claims description 40
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 32
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 11
- 235000013305 food Nutrition 0.000 claims description 9
- 235000015218 chewing gum Nutrition 0.000 claims description 8
- 229940112822 chewing gum Drugs 0.000 claims description 7
- 235000013336 milk Nutrition 0.000 claims description 6
- 239000008267 milk Substances 0.000 claims description 6
- 210000004080 milk Anatomy 0.000 claims description 6
- 235000013618 yogurt Nutrition 0.000 claims description 5
- 239000002324 mouth wash Substances 0.000 claims description 4
- 230000001013 cariogenic effect Effects 0.000 claims description 3
- 230000012010 growth Effects 0.000 claims description 3
- 235000019482 Palm oil Nutrition 0.000 claims description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000002540 palm oil Substances 0.000 claims description 2
- 241001122767 Theaceae Species 0.000 claims 2
- 235000015895 biscuits Nutrition 0.000 claims 2
- 235000013351 cheese Nutrition 0.000 claims 2
- 235000019219 chocolate Nutrition 0.000 claims 2
- 235000009508 confectionery Nutrition 0.000 claims 2
- 235000015094 jam Nutrition 0.000 claims 2
- 239000007937 lozenge Substances 0.000 claims 2
- 229940051866 mouthwash Drugs 0.000 claims 2
- 235000011962 puddings Nutrition 0.000 claims 2
- 235000013616 tea Nutrition 0.000 claims 2
- 235000012431 wafers Nutrition 0.000 claims 2
- 241000194019 Streptococcus mutans Species 0.000 abstract description 39
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract description 8
- 208000002064 Dental Plaque Diseases 0.000 abstract description 6
- 239000003795 chemical substances by application Substances 0.000 abstract description 5
- 239000004310 lactic acid Substances 0.000 abstract description 4
- 235000014655 lactic acid Nutrition 0.000 abstract description 4
- 241000124008 Mammalia Species 0.000 abstract description 3
- 238000011321 prophylaxis Methods 0.000 abstract description 3
- 239000000047 product Substances 0.000 description 32
- 210000004027 cell Anatomy 0.000 description 20
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 15
- 239000002953 phosphate buffered saline Substances 0.000 description 15
- 239000000725 suspension Substances 0.000 description 14
- 239000002207 metabolite Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 8
- 210000000214 mouth Anatomy 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 7
- 241000282412 Homo Species 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 210000003097 mucus Anatomy 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- 230000003698 anagen phase Effects 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 101710179738 6,7-dimethyl-8-ribityllumazine synthase 1 Proteins 0.000 description 3
- 102000009338 Gastric Mucins Human genes 0.000 description 3
- 108010009066 Gastric Mucins Proteins 0.000 description 3
- 101710186608 Lipoyl synthase 1 Proteins 0.000 description 3
- 101710137584 Lipoyl synthase 1, chloroplastic Proteins 0.000 description 3
- 101710090391 Lipoyl synthase 1, mitochondrial Proteins 0.000 description 3
- PQMWYJDJHJQZDE-UHFFFAOYSA-M Methantheline bromide Chemical compound [Br-].C1=CC=C2C(C(=O)OCC[N+](C)(CC)CC)C3=CC=CC=C3OC2=C1 PQMWYJDJHJQZDE-UHFFFAOYSA-M 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 229940071604 biogaia Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 230000000529 probiotic effect Effects 0.000 description 3
- 238000010187 selection method Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 241000917009 Lactobacillus rhamnosus GG Species 0.000 description 2
- 241000186869 Lactobacillus salivarius Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 2
- 230000002053 acidogenic effect Effects 0.000 description 2
- 230000003217 anti-cancerogenic effect Effects 0.000 description 2
- 230000000170 anti-cariogenic effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000001055 chewing effect Effects 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000021045 dietary change Nutrition 0.000 description 2
- 235000013681 dietary sucrose Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 108010050327 trypticase-soy broth Proteins 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- AKXKFZDCRYJKTF-UHFFFAOYSA-N 3-Hydroxypropionaldehyde Chemical compound OCCC=O AKXKFZDCRYJKTF-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 241000186044 Actinomyces viscosus Species 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010037833 Bacterial Adhesins Proteins 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
- 241000535428 Lactobacillus reuteri DSM 20016 Species 0.000 description 1
- 241001616647 Lactobacillus reuteri MM2-3 Species 0.000 description 1
- 241000553356 Lactobacillus reuteri SD2112 Species 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- 241000577554 Lactobacillus zeae Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- -1 for example Proteins 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 108010020998 gassericin A Proteins 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000003869 genetically modified organism Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000008986 metabolic interaction Effects 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/366—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G4/123—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C2260/00—Particular aspects or types of dairy products
- A23C2260/25—Dairy compositions providing for tooth protective effects, e.g. anticariogenic effects
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/869,185 US7517681B2 (en) | 2003-01-29 | 2004-06-14 | Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
| US10/869,185 | 2004-06-14 | ||
| PCT/SE2005/000805 WO2005121312A1 (en) | 2004-06-14 | 2005-05-30 | Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0511372A BRPI0511372A (pt) | 2007-12-04 |
| BRPI0511372B1 true BRPI0511372B1 (pt) | 2020-09-15 |
Family
ID=35503056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0511372-5A BRPI0511372B1 (pt) | 2004-06-14 | 2005-05-30 | Produto para inibição do crescimento de bactérias de cárie dentária, e, método para fabricar um produto |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7517681B2 (enExample) |
| EP (1) | EP1765975A1 (enExample) |
| JP (2) | JP5566007B2 (enExample) |
| KR (2) | KR101143734B1 (enExample) |
| CN (1) | CN1981028A (enExample) |
| AU (1) | AU2005252605B2 (enExample) |
| BR (1) | BRPI0511372B1 (enExample) |
| CA (1) | CA2569141C (enExample) |
| IN (2) | IN244537B (enExample) |
| MX (1) | MX287430B (enExample) |
| NZ (1) | NZ552585A (enExample) |
| SG (1) | SG128035A1 (enExample) |
| WO (1) | WO2005121312A1 (enExample) |
| ZA (1) | ZA200700210B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7517681B2 (en) * | 2003-01-29 | 2009-04-14 | Biogaia Ab | Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
| CN101273738B (zh) * | 2007-03-28 | 2011-06-01 | 哈尔滨正方科技有限公司 | 在常温下保持高活菌数的调配型酸性乳饮料的制备方法 |
| PL2318511T3 (pl) * | 2008-08-28 | 2018-01-31 | Chr Hansen As | Kompozycja bakteryjna |
| EP2361081B1 (en) * | 2008-10-14 | 2016-06-29 | McNeil AB | Multi portion intra-oral dosage form and use thereof |
| DK2455095T3 (en) | 2009-07-16 | 2017-07-24 | Univ Hiroshima | PROPHYLACTIC, IMPROVING OR THERAPEUTIC AGENT FOR ORAL DISEASES |
| US20110293710A1 (en) * | 2010-02-02 | 2011-12-01 | Delphine Saulnier | Immunomodulatory properties of lactobacillus strains |
| IT1398648B1 (it) * | 2010-03-09 | 2013-03-08 | Probiotical Spa | Prodotto alimentare comprendente batteri probiotici rivestiti con un rivestimento di origine vegetale. |
| JP2012092094A (ja) * | 2010-09-30 | 2012-05-17 | Wakamoto Pharmaceutical Co Ltd | 油脂中に乳酸菌を含有する口腔用組成物 |
| GB201206599D0 (en) | 2012-04-13 | 2012-05-30 | Univ Manchester | Probiotic bacteria |
| AU2014254812B2 (en) * | 2013-04-17 | 2019-06-13 | Suntory Holdings Limited | Bacterium belonging to genus Lactobacillus |
| MY183171A (en) | 2013-04-17 | 2021-02-18 | Suntory Holdings Ltd | Composition containing bacterium belonging to genus lactobacillus |
| CN103478390B (zh) * | 2013-08-13 | 2015-04-15 | 华侨大学 | 一种预防和辅助治疗牙周炎的口香糖的制备方法 |
| KR102095339B1 (ko) * | 2017-06-01 | 2020-05-27 | 한국생명공학연구원 | 신규한 락토바실러스 류테리 균주 및 이를 유효성분으로 포함하는 치주질환 예방 또는 치료용 조성물 |
| KR101966772B1 (ko) * | 2017-07-11 | 2019-04-09 | 주식회사 다케어 | 락토바실러스 루테리 cs 132(kctc 11452bp) 또는 이의 배양물을 포함하는 구강병원균 억제조성물 |
| KR102001074B1 (ko) * | 2018-12-07 | 2019-07-18 | 주식회사 메디오젠 | 충치 억제 활성을 갖는 유산균 조성물 |
| KR102230517B1 (ko) * | 2019-07-09 | 2021-03-22 | 주식회사 메디오젠 | 충치 억제 활성을 갖는 락토바실러스 살리바리우스를 포함하는 조성물 |
| KR102210092B1 (ko) * | 2019-07-09 | 2021-02-01 | 주식회사 메디오젠 | 충치 억제 활성을 갖는 락토바실러스 루테리 mg505 를 포함하는 조성물 |
| IT202100000176A1 (it) * | 2021-01-07 | 2022-07-07 | Metis Healthcare S R L | Preparazioni orali a base di carnosina ad attività antivirale |
| KR102736620B1 (ko) * | 2021-06-23 | 2024-12-03 | 주식회사 웰빙엘에스 | 스트렙토코커스 뮤탄스 억제 및 항염증 효능을 갖는 신규한 락토바실러스 애시도필러스 균주 및 이의 용도 |
| CN113652340A (zh) * | 2021-08-24 | 2021-11-16 | 江苏江大源生态生物科技股份有限公司 | 一种益生菌制剂、菌种筛选装置及筛选方法 |
| JPWO2023063314A1 (enExample) | 2021-10-11 | 2023-04-20 | ||
| JP2023172607A (ja) * | 2022-05-24 | 2023-12-06 | 株式会社アデランス | 乳酸菌含有ガム |
| CN116650390A (zh) * | 2023-02-01 | 2023-08-29 | 苏州抓马生物科技有限公司 | 一种专效修复抗敏的无水配方牙膏 |
| KR102637772B1 (ko) | 2023-09-21 | 2024-02-20 | 주식회사 큐옴바이오 | 위건강과 구강질환 관련 미생물 및 병원성 미생물에 대한 항균활성을 갖는 산삼 유래 락토바실러스 플란타럼 wg.q7 균주 및 이의 용도 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH637297A5 (fr) * | 1978-12-05 | 1983-07-29 | Nestle Sa | Microbille comprenant un microorganisme et son procede de fabrication. |
| CA1262442A (en) * | 1984-03-09 | 1989-10-24 | Yasuo Kawai | Anticariogenic or antiperiodontitic agent |
| US5413960A (en) * | 1987-05-01 | 1995-05-09 | Biogaia Ab | Antibiotic reuterin |
| FR2672494A1 (fr) | 1991-02-13 | 1992-08-14 | Madinier Isabelle | Ferments prophylactiques favorisant la prevention de la carie dentaire. |
| NZ325131A (en) * | 1995-12-21 | 2000-08-25 | Abbott Lab | Inhibiting mammalian cryptosporidiosis using Lactobacillus reuteri |
| US5837238A (en) * | 1996-06-05 | 1998-11-17 | Biogaia Biologics Ab | Treatment of diarrhea |
| US5800813A (en) * | 1996-11-12 | 1998-09-01 | Biogaia Biologics Ab | Treatment of cryptosporidium infections |
| KR19990024297A (ko) * | 1997-08-07 | 1999-04-06 | 오종석 | 인체 구강내 치태형성을 억제하는 신규한 유산균 |
| US6100388A (en) * | 1998-03-16 | 2000-08-08 | Biogaia Biologies Ab | Lactobacilli harboring aggregation gene as a vaccine delivery vehicle |
| US6461607B1 (en) * | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
| GB9920578D0 (en) | 1999-08-31 | 1999-11-03 | Nestle Sa | Composition for maintenance of bone or dental health or treatment of bone or dental disorders |
| JP3363438B2 (ja) * | 2000-05-02 | 2003-01-08 | ビオフェルミン製薬株式会社 | 噴霧乾燥による菌体乾燥物 |
| JP3824312B2 (ja) * | 2000-05-02 | 2006-09-20 | ビオフェルミン製薬株式会社 | 噴霧乾燥による菌体乾燥物 |
| JP2003299480A (ja) * | 2002-04-09 | 2003-10-21 | Hiroki Futagawa | 虫歯予防用細菌、虫歯予防用食品、虫歯予防用口腔洗浄剤及びヨーグルトの製造方法 |
| US7517681B2 (en) * | 2003-01-29 | 2009-04-14 | Biogaia Ab | Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
| US6872565B2 (en) * | 2003-01-29 | 2005-03-29 | Biogaia Ab | Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries |
-
2004
- 2004-06-14 US US10/869,185 patent/US7517681B2/en not_active Expired - Lifetime
-
2005
- 2005-05-30 IN IN7653DN2006 patent/IN244537B/en unknown
- 2005-05-30 BR BRPI0511372-5A patent/BRPI0511372B1/pt active IP Right Grant
- 2005-05-30 CN CNA2005800192636A patent/CN1981028A/zh active Pending
- 2005-05-30 EP EP05747457A patent/EP1765975A1/en not_active Ceased
- 2005-05-30 WO PCT/SE2005/000805 patent/WO2005121312A1/en not_active Ceased
- 2005-05-30 KR KR1020067025744A patent/KR101143734B1/ko not_active Expired - Lifetime
- 2005-05-30 ZA ZA200700210A patent/ZA200700210B/en unknown
- 2005-05-30 NZ NZ552585A patent/NZ552585A/en not_active IP Right Cessation
- 2005-05-30 JP JP2007527129A patent/JP5566007B2/ja not_active Expired - Lifetime
- 2005-05-30 CA CA2569141A patent/CA2569141C/en not_active Expired - Lifetime
- 2005-05-30 KR KR1020117017996A patent/KR101261172B1/ko not_active Expired - Fee Related
- 2005-05-30 AU AU2005252605A patent/AU2005252605B2/en not_active Ceased
- 2005-05-30 SG SG200608464A patent/SG128035A1/en unknown
-
2006
- 2006-12-13 MX MXPA06014516 patent/MX287430B/es active IP Right Grant
- 2006-12-18 IN IN7653DE2006 patent/IN2006DE07653A/xx unknown
-
2012
- 2012-04-12 JP JP2012090915A patent/JP2012130358A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20050002874A1 (en) | 2005-01-06 |
| KR20070030819A (ko) | 2007-03-16 |
| IN2006DE07653A (en) | 2007-08-17 |
| KR101261172B1 (ko) | 2013-05-09 |
| JP5566007B2 (ja) | 2014-08-06 |
| MX287430B (es) | 2011-06-13 |
| CA2569141C (en) | 2012-05-29 |
| WO2005121312A1 (en) | 2005-12-22 |
| AU2005252605B2 (en) | 2010-08-12 |
| IN244537B (enExample) | 2010-12-17 |
| JP2012130358A (ja) | 2012-07-12 |
| CA2569141A1 (en) | 2005-12-22 |
| AU2005252605A1 (en) | 2005-12-22 |
| CN1981028A (zh) | 2007-06-13 |
| SG128035A1 (en) | 2007-01-30 |
| KR101143734B1 (ko) | 2012-05-10 |
| ZA200700210B (en) | 2008-05-28 |
| KR20110093951A (ko) | 2011-08-18 |
| EP1765975A1 (en) | 2007-03-28 |
| NZ552585A (en) | 2009-08-28 |
| US7517681B2 (en) | 2009-04-14 |
| JP2008502360A (ja) | 2008-01-31 |
| MXPA06014516A (es) | 2007-03-12 |
| BRPI0511372A (pt) | 2007-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0511372B1 (pt) | Produto para inibição do crescimento de bactérias de cárie dentária, e, método para fabricar um produto | |
| US8343483B2 (en) | Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries | |
| JP5879349B2 (ja) | 口腔衛生のためのプロバイオティック組成物 | |
| BR112012018813B1 (pt) | composição compreendendo cepas bacterianas com atividade anti-inflamatória, imunomoduladora, antiibs ou antidistensão abdominal, uso das mesmas, bem como produtos farmacêutico, veterinário e comestível compreendendo a referida composição | |
| US20090238774A1 (en) | Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation | |
| CN109480231A (zh) | 抗幽门螺杆菌的组合物及其应用 | |
| CN109414465B (zh) | 益生菌组合物及其用途 | |
| AU2011202947B2 (en) | Feline probiotic lactobacilli | |
| HK1101411A (en) | Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries | |
| Acharya | Probiotics: current knowledge update | |
| CN114796287A (zh) | 一种可预防龋齿和清新口腔的益生菌粉及其应用 | |
| HK1094455B (en) | Use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries | |
| ES2973007A1 (es) | Probiotico oral |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: C12N 1/20 (2006.01), A61K 35/747 (2015.01), A61P 1 |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/09/2020, OBSERVADAS AS CONDICOES LEGAIS. |